Charting A Direct Pathway From Academia To CDMOs

Promising science is moving out of university labs faster than ever, but the path from academic discovery to outsourced development and manufacturing is rarely simple. As university technology transfer offices, principal investigators, and early-stage innovators seek to engage CDMOs earlier, many programs encounter a familiar challenge: great research does not always include the documentation, development strategy, quality expectations, or manufacturing context needed for a smooth handoff.

This Outsourced Pharma Live discussion will explore how academic programs can become more CDMO-ready, what CDMOs need to see before supporting scale-up or early manufacturing runs, and how both sides can bridge the language gap between research science and real-world execution. Panelists will share practical perspectives on building better technical packages, aligning earlier around timelines and quality systems, and creating a more efficient path from the university lab to the CDMO suite.